Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China.
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Duloxetine (Primary)
- Indications Generalised anxiety disorder
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 01 Nov 2011 Results published in the Chinese Medical Journal.
- 06 Jul 2010 Registrational comment added and comment about regulatory requirement.
- 06 Jun 2010 Patient recruitment details and results were presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum. Results of the study were not provided in the abstract.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History